PAST EVENTS
PAST EVENTS AND RESOURCESWelcome to our Archive of past GIPC presentations. The Group Insurance & Pharmaceutical Committee makes selected portions of the archive available directly here on our web site for download and use by our industry associates. All archived presentations are available in Adobe Portable Document Format (PDF).
The Next Frontier
September 25, 2024
Drug Benefits: Policy and Trends Updates
April 10, 2024
Future-proofing Your Plan
November 2, 2023
What’s Happening Now and what’s next?
May 3, 2023
Creating Value Through Collaboration
November 8, 2022
A New Era of Innovation
April 12, 2022
The Next Evolution
November 17, 2021
A New Era of Collaboration
April 8, 2021
The Next Frontier
pharmaceutical Industry Policy Update
Regina Lisi, Director, Private Market Access, Innovative Medicines Canada
Group Insurance Industry Policy Update
Sheila Burns, Director, Health and Disability Policy, Canadian Life and Health Insurance Association Inc.
Future Landscape: What’s Coming in the Drug Pipeline that you’ll want to know about
Mark Omoto, GM Thought Leadership Marketing & Communications, IQVIA
Patient Group Perspectives on Private Health Insurance
Robert Bick, Co-Lead, CanCertainty
Obesity: A Key Determinant of Health, Career Sustainability, and Workforce Productivity
Sandra Elia, Chair, Obesity Matters, Certified Food Addiction Counselor
Drug Benefits: Policy and Trends Updates
Group Insurance Industry Policy Update
Sheila Burns, Director, Health and Disability Policy, Canadian Life and Health Insurance Association Inc.
Pharmaceutical Industry Policy Update
Joe Farago, Executive Director, Private Payers and Investment, Innovative Medicines Canada
Drug Benefits: Policy and Trends Updates
For past registrants of the GIPC Spring Virtual Webinar which took place on April 10, 2024, please click here to watch the recording of the session. Password is required for access.
Future-proofing your plan
Setting the Context – Pharmaceutical Industry Policy Update
Joe Farago, Executive Director, Private Payers and Investment, Innovative Medicines Canada
Future Landscape: What’s Coming in the Pipeline
Brad Millson, General Manager of Real World Solutions, IQVIA Canada
Future Proofing for Next Generation Therapies: Drugs for Rare Disease
Rute Fernandes, President and General Manager, Takeda Canada Inc.
Future Access to Cancer Treatments for People in the Workplace: Patient’s Perspective
Yelena Aizenberg, Cancer Survivor; ICU Nurse, Sickkids Hospital, Patient Advocate
Evolving Role of the Pharmacist: Emerging Scope of Pharmacy Practice
Dr. Nardine Nakhla, PharmD, RPh; Associate Professor, Teaching Stream at University of Waterloo School of Pharmacy;
CEO and co-founder of MAPflow Inc.
Challenges Facing the Employer: Ideas for Future Proofing Plans and Managing the Changing Expectations of Plan Members
Mark Goldasic, Partner, Jones DesLauriers, Group Benefits & Retirement
Shana Kapustin, Senior Director of Human Resources, TD SYNNEX Canada
What’s Happening Now and What’s Next? (May 3, 2023)
Setting the Context – Pharmaceutical Industry Policy Update
Joe Farago, Executive Director, Private Payers and Investment, Innovative Medicines Canada
Exploring Innovative Agreements in Public Pharmaceutical Programs
John Sproule, Senior Policy Director, Institute of Health Economics
What's Happening Now and What's Next?
For past registrants of the GIPC Spring Virtual Webinar which took place on May 3, 2023, please click here to watch the recording of the session. Password is required for access.
Creating Value Through Collaboration (November 8, 2022)
Poll Results
Setting the Context - Pharmaceutical Industry Policy Update
Joe Farago, Executive Director, Private Payers and Investment, Innovative Medicines Canada
Setting the context - Group Insurance & Pharmaceutical Industry Policy Update
Sheila Burns, Director, Health and Disability Policy, Canadian Life and Health Insurance Association Inc.
The Conference Board of Canada Report on Public and Private Drug Coverage
Isabelle Gagnon-Arpin, Principal Research Associate, Health, The Conference Board of Canada
Prevention Strategies for the Workplace: Mental Health, Wellness and Chronic Disease Management
Eric Pfeiffer, Senior Health and Wellness Consultant, Manulife
Investing in Private Health Benefits – Worth the Risk
Sandra Ventin, Associate VP, Benefits, Gallagher & Associates
Steven Sfikas, Benefits Manager, Americas Talent & Culture, Morningstar
A New Era of Innovation (April 12, 2022)
Collaboration to Advance Private Health Benefits: Lessons from the Pandemic
Cole Pinnow, President of Pfizer Canada
Setting the Context – Group Insurance Industry Policy Update
Joan Weir, VP Group Benefits, Canadian Life and Health Insurance Association
Setting the Context – Pharmaceutical Industry Policy Update
Joe Farago, Executive Director, Private Payers and Investment, Innovative Medicines Canada
A New Era of Innovation
For past registrants of the GIPC Spring Virtual Webinar which took place on April 12, 2022, please click here to watch the recording of the session. Password is required for access.
The Next Evolution (November 17, 2021)
Setting the Context – Pharmaceutical Industry Policy Update
Joe Farago, Executive Director, Private Payers and Investment, Innovative Medicines Canada
Utilization of Spending Accounts and Changes to Benefit Plans Resulting from a Remote Workforce
Tim Kane, Chief Executive Officer, myHSA Ltd.
SOLUTIONS AND OPPORTUNITIES FOR DRUG BENEFIT PLANS THROUGH THE LENS OF DIVERSITY AND INCLUSION
Jennifer Schmidt, Principal, Health, Mercer Canada
A New Era Of Collaboration (April 8, 2021)
Setting the Context – Group Insurance Industry Policy Update
Karen Voin, VP Group Benefits and Anti-Fraud, Canadian Life and Health Insurance Association Inc.
Setting the Context – Pharmaceutical Industry Policy Update
Joe Farago, Executive Director, Private Payers and Investment, Innovative Medicines Canada
Strategies for Addressing Delays in Diagnosis and Treatment
Lise D’Andrea, Manager Health and Ability Strategy, Canada Life Assurance Company
we want to hear from you.
The Group Insurance & Pharmaceutical Committee – GIPC.
Committed to bringing you the highest quality and relevant industry content and resources.
For over a decade the Group Insurance & Pharmaceutical Committee (GIPC) has provided timely relevant educational workshops to individuals from a variety of professional backgrounds. We feature high quality presenters in an interactive exchange of information on the most pressing issues of the day for plan sponsors, advisors and pharmaceutical firms.